Simris Group AB (PUBL) (STO:SIMRIS.B)
Sweden · Delayed Price · Currency is SEK 0.1425
-0.0295 (-17.15%)
At close: Feb 10, 2026
Simris Group AB (PUBL) Market Cap
Simris Group AB (PUBL) has a market cap or net worth of 167.02 million as of February 11, 2026. Its market cap has increased by 437.96% in one year.
Market Cap
167.02M
Enterprise Value
163.23M
Revenue
2.30M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since April 22, 2016, Simris Group AB (PUBL)'s market cap has increased from 122.27M to 167.02M, an increase of 36.60%. That is a compound annual growth rate of 3.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 167.02M | 524.25% |
| Dec 30, 2025 | 26.76M | 0.88% |
| Dec 30, 2024 | 26.52M | -66.13% |
| Dec 29, 2023 | 78.32M | 72.71% |
| Dec 30, 2022 | 45.35M | -21.98% |
| Dec 30, 2021 | 58.12M | 3.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Apr 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xintela AB | 244.60M |
| Elicera Therapeutics AB | 242.44M |
| Magle Chemoswed Holding AB | 231.27M |
| AlzeCure Pharma AB | 226.96M |
| Xbrane Biopharma AB | 218.38M |
| Initiator Pharma | 205.36M |
| Sprint Bioscience AB | 197.31M |
| Isofol Medical AB | 168.52M |